Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

For a study in BMC Public Health, Ph.D. student Farhan Mohsin and colleagues examined the prevalence and risk factors of ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

Alerts delivered via the electronic health record temporarily reduces unnecessary screening and treatment but does not create ...

Resilience factors were associated with less severe positive and negative schizophrenia symptoms, suggesting resilience may play a protective role.

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...